Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCPA.L Regulatory News (SCPA)

  • There is currently no data for SCPA

Directorate Change

28 Jan 2016 07:00

RNS Number : 2335N
Scapa Group PLC
28 January 2016
 

28 January 2016

Scapa Group plc

('Scapa' or 'the Company')

 

Directorate Change and Director Dealing

 

Scapa, a global manufacturer of bonding materials and solutions, announces that Paul Edwards has notified the Board of his intention to retire from his role as Group Finance Director on 30 April 2016. Paul Edwards has served as Group Finance Director since September 2010. He will remain with the Company in an advisory capacity until 31 October 2016.

Following a thorough and wide reaching search, the Board is delighted also to announce the appointment of Graham Hardcastle as Group Finance Director, to take effect when Paul Edwards steps down from the Board on 30 April 2016. Graham Hardcastle joins the Board with effect from 1 February 2016. He was previously Group Finance Director at Bridon International and prior to that he held a number of senior finance positions at Smith & Nephew plc and Smiths Group plc.

James Wallace, Chairman of the Board, commented: "The Board thanks Paul for his contribution to the success of the Company during his tenure. He helped lead the Company during a period of exceptional development and the Board wishes him well for the future. Graham brings to the role very strong business skills and experience in healthcare and global markets, which will be of great benefit to the Group as it pursues its strategy for growth."

The Company makes the following disclosures in relation to Graham Hardcastle's appointment in accordance with paragraph (g) of Schedule Two of the AIM Rules for Companies:

1. Director's full name: Graham Stuart Hardcastle

 

Director's age: 51 years

2. Other directorships / partnerships held during the last five years:

Name of Company / Partnership:

 

Bridon Scheme Trustees Limited

 

Bridon (Hanghou) Ropes Co Ltd

 

Bridon Scanrope AS

 

Bridon TopCo (Jersey) Ltd

 

Bridon Singapore (PTE) Limited

 

Bridon Hangzhou Limited (China)

 

Bridon South East Asia Limited

 

Bridon Hong Kong Limited

 

PT Bridon

 

Smith and Nephew Orthopedics Beijing Limited

 

Mr. Hardcastle is no longer a director of any of the aforementioned companies.

3. Other information: there is no other information required to be disclosed under paragraph (g) of Schedule Two of the AIM Rules for Companies.

 

Director Dealing

The Company also announces that the Remuneration Committee has approved the grant of awards to the Executive Directors and other Senior Executives under the Scapa Group plc 2015 Value Creation Plan, effective 1 February 2016. Details of the Value Creation Plan are set out in the Circular posted to Shareholders on 29 October 2015. The awards are in the form of nil cost options and those granted to the Executive Directors are disclosed in the table below:

Name

Job title

Award - Proportion of Value Creation Plan

Heejae Chae

Chief Executive

40%

Graham Hardcastle

Group Finance Director

20%

 

 

Enquiries:

Rebecca Smith, Company Secretary Tel: 0161 301 7430

Scapa Group plc

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOASELESWFMSEIF
Date   Source Headline
2nd Jul 20184:33 pmRNSTotal Voting Rights
28th Jun 20184:12 pmRNSDirector/PDMR Shareholding
5th Jun 20184:00 pmRNSDirector/PDMR Shareholding
31st May 201810:31 amRNSTotal Voting Rights
30th May 201810:20 amRNSDirector/PDMR Shareholding
22nd May 20187:00 amRNSFinal Results
30th Apr 201810:30 amRNSTotal Voting Rights
12th Apr 20187:00 amRNSTrading Statement
11th Apr 20183:29 pmRNSIncident at Dunstable Site
29th Mar 201811:48 amRNSTotal Voting Rights
26th Mar 20187:00 amRNSAcquisition
28th Feb 20181:38 pmRNSTotal Voting Rights
7th Feb 20189:17 amRNSBlock listing Interim Review
31st Jan 20189:08 amRNSTotal Voting Rights
25th Jan 20182:14 pmRNSBlock listing Interim Review
8th Jan 201810:10 amRNSDirectorate Change
7th Dec 20173:52 pmRNSDirector/PDMR Shareholding
7th Dec 20173:49 pmRNSAdditional Listing
29th Nov 201711:15 amRNSDirector/PDMR Shareholding
28th Nov 20172:56 pmRNSDirector/PDMR Shareholding
28th Nov 20172:44 pmRNSDirector/PDMR Shareholding
23rd Nov 20179:36 amRNSDirector/PDMR Shareholding
21st Nov 20177:00 amRNSHalf-year Report
17th Nov 201710:22 amRNSAdditional Listing
11th Oct 20177:00 amRNSTrading Statement
4th Oct 20177:00 amRNSCapital Markets Day
26th Sep 201711:38 amRNSAdditional Listing
21st Sep 20174:21 pmRNSHolding(s) in Company
8th Sep 201711:31 amRNSDirector/PDMR Shareholding
4th Sep 20173:18 pmRNSDirector/PDMR Shareholding
4th Sep 201710:13 amRNSAdditional Listing
25th Aug 20177:00 amRNSDirector/PDMR Shareholding
17th Aug 20174:14 pmRNSDirector/PDMR Shareholding
11th Aug 20174:12 pmRNSDirector/PDMR Shareholding
9th Aug 20177:00 amRNSAcquisition
7th Aug 20171:56 pmRNSBlock listing Interim Review
25th Jul 201710:09 amRNSBlock listing Interim Review
19th Jul 20179:29 amRNSHolding(s) in Company
18th Jul 20177:00 amRNSAGM Statement
1st Jun 20171:59 pmRNSHolding(s) in Company
30th May 20172:09 pmRNSAdditional Listing
23rd May 20177:00 amRNSFinal Results
18th May 20173:47 pmRNSHolding(s) in Company
17th May 20173:36 pmRNSHolding(s) in Company
3rd May 201710:31 amRNSAdditional Listing
21st Apr 20179:41 amRNSHolding(s) in Company
19th Apr 20173:33 pmRNSAdditional Listing
13th Apr 20177:00 amRNSTrading Statement
27th Mar 20172:05 pmRNSDirector/PDMR Shareholding
23rd Mar 201711:46 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.